210 related articles for article (PubMed ID: 19582874)
1. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
Wickersheim A; Kerber M; de Miguel LS; Plate KH; Machein MR
Int J Cancer; 2009 Oct; 125(8):1771-7. PubMed ID: 19582874
[TBL] [Abstract][Full Text] [Related]
2. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.
He Y; Rajantie I; Ilmonen M; Makinen T; Karkkainen MJ; Haiko P; Salven P; Alitalo K
Cancer Res; 2004 Jun; 64(11):3737-40. PubMed ID: 15172976
[TBL] [Abstract][Full Text] [Related]
3. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
[TBL] [Abstract][Full Text] [Related]
4. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
5. The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth.
Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Yu D; Zhou X; Ding Y
Oncol Rep; 2012 Oct; 28(4):1217-24. PubMed ID: 22858892
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature.
Bonfim-Silva R; Souza LE; Melo FU; Oliveira VC; Magalhães DA; Oliveira HF; Covas DT; Fontes AM
Clin Transl Oncol; 2017 Jan; 19(1):125-133. PubMed ID: 27188167
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.
Shinde Patil VR; Friedrich EB; Wolley AE; Gerszten RE; Allport JR; Weissleder R
Neoplasia; 2005 Mar; 7(3):234-40. PubMed ID: 15799823
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors.
Liang PH; Tian F; Lu Y; Duan B; Stolz DB; Li LY
Angiogenesis; 2011 Mar; 14(1):61-8. PubMed ID: 21188501
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
[TBL] [Abstract][Full Text] [Related]
10. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
Li H; Gerald WL; Benezra R
Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization.
Watson AR; Pitchford SC; Reynolds LE; Direkze N; Brittan M; Alison MR; Rankin S; Wright NA; Hodivala-Dilke KM
J Pathol; 2010 Mar; 220(4):435-45. PubMed ID: 19967726
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.
Gao D; Nolan DJ; Mellick AS; Bambino K; McDonnell K; Mittal V
Science; 2008 Jan; 319(5860):195-8. PubMed ID: 18187653
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.
Nolan DJ; Ciarrocchi A; Mellick AS; Jaggi JS; Bambino K; Gupta S; Heikamp E; McDevitt MR; Scheinberg DA; Benezra R; Mittal V
Genes Dev; 2007 Jun; 21(12):1546-58. PubMed ID: 17575055
[TBL] [Abstract][Full Text] [Related]
14. Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells.
Young MR
Int J Cancer; 2004 Apr; 109(4):516-24. PubMed ID: 14991572
[TBL] [Abstract][Full Text] [Related]
15. Bone-marrow-derived endothelial progenitor cells contribute to vasculogenesis of pregnant mouse uterus†.
Tal R; Dong D; Shaikh S; Mamillapalli R; Taylor HS
Biol Reprod; 2019 May; 100(5):1228-1237. PubMed ID: 30601943
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth.
Muramatsu M; Yamamoto S; Osawa T; Shibuya M
Cancer Res; 2010 Oct; 70(20):8211-21. PubMed ID: 20924106
[TBL] [Abstract][Full Text] [Related]
17. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45.
Shaw JP; Basch R; Shamamian P
Blood Cells Mol Dis; 2004; 32(1):168-75. PubMed ID: 14757432
[TBL] [Abstract][Full Text] [Related]
19. Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth.
Mellick AS; Plummer PN; Nolan DJ; Gao D; Bambino K; Hahn M; Catena R; Turner V; McDonnell K; Benezra R; Brink R; Swarbrick A; Mittal V
Cancer Res; 2010 Sep; 70(18):7273-82. PubMed ID: 20807818
[TBL] [Abstract][Full Text] [Related]
20. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo.
Murayama T; Tepper OM; Silver M; Ma H; Losordo DW; Isner JM; Asahara T; Kalka C
Exp Hematol; 2002 Aug; 30(8):967-72. PubMed ID: 12160849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
